Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.425
Neutral
RSI(14)
53.241
Neutral
STOCH(KDJ)(9,3,3)
52.622
Buy
ATR(14)
0.958
High Vlolatility
CCI(14)
-54.595
Neutral
Williams %R
64.849
Sell
TRIX(12,20)
0.310
Sell
StochRSI(14)
84.113
Buy
Search
QuidelOrtho Corp
QDELAdd to Watchlist
16.770USD
+0.200+1.21%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.14BMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
+1.21%
5 Days
+4.49%
1 Month
-8.11%
6 Months
-39.35%
Year to Date
-41.28%
1 Year
-26.48%
Key Figures
16.550Open
16.860High
739.54KVolume
LossP/E TTM
6.70P/E Dynamic
--Dividend TTM
1.09%Turnover Ratio
16.570Prev. Close
16.000Low
9.97MTurnover
LossP/E Static
0.62P/B
0.00%Div Yield TTM
-20.03%ROA
35.57552wk High
0.71Volume Ratio
-2.05BNet Profit
68.10MShares
-17.8511EPS TTM
0.77Beta
-49.95%ROE
9.92052wk Low
5.19%Amplitude
35.01%Gross Margin
1.14BMarket Cap
-1.86Reward/Risk
4.28%Risk Rate
TradingKey Stock Score of QuidelOrtho Corp
Currency: USD Updated: 2026-07-31Key Insights
QuidelOrtho Corp's fundamentals are relatively stable, and its growth potential is significant.Its valuation is considered fairly valued, ranking 84 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 23.33.In the medium term, the stock price is expected to trend up.The company has shown weak stock market performance over the past month, in line with its weak fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
QuidelOrtho Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
QuidelOrtho Corp Highlights
StrengthsRisks
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 2.73B.
Overvalued
The company’s latest PE is -0.94, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 88.33M shares, decreasing 13.83% quarter-over-quarter.
Held by Paul Tudor Jones
Star Investor Paul Tudor Jones holds 312.25K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.14.
Analyst Rating
Based on
3
analysts
Hold
Current Rating
26.000
Target Price
+55.04%
Upside Space
QuidelOrtho Corp News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
3
analysts
Hold
Current Rating
26.000
Target Price
+55.04%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
88
Total
4
Median
7
Average
Company name
Ratings
Analysts
QuidelOrtho Corp
QDEL
3
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Veeva Systems Inc
VEEV
30
Thermo Fisher Scientific Inc
TMO
30
1
2
3
...
18
Indicators
Moving Average
Indicators
Value
Direction
MA5
16.668
Buy
MA10
16.566
Buy
MA20
17.151
Sell
MA50
15.220
Buy
MA100
14.671
Buy
MA200
20.858
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
QuidelOrtho Corp Info
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.
Ticker SymbolQDEL
CompanyQuidelOrtho Corp
CEOBlaser (Brian J)
Websitehttps://www.quidelortho.com/
Shareholders
Related Instruments
-1.72%
-0.43%
+0.12%
-0.59%
-0.74%
-6.42%
+0.10%
-0.36%
+1.75%
-0.14%
-2.99%
+1.58%
-0.29%
+0.41%
-1.02%
+0.13%
+0.05%
-0.80%
-0.24%
-0.70%Popular Instruments
52788.200
+410.200 (+0.78%)
28507.100
+346.200 (+1.23%)
7534.900
+59.800 (+0.80%)
14622.000
-127.000 (-0.86%)
63590.000
+738.000 (+1.17%)
6405.700
+40.300 (+0.63%)
78.530
-7.404 (-8.62%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4058.400
+16.970 (+0.42%)
FAQs
What is the current price of QuidelOrtho Corp (QDEL)?
The current price of QuidelOrtho Corp (QDEL) is 16.77.
What is the symbol of QuidelOrtho Corp?
The ticker symbol of QuidelOrtho Corp is QDEL.
What is the 52-week high of QuidelOrtho Corp?
The 52-week high of QuidelOrtho Corp is 35.58.
What is the 52-week low of QuidelOrtho Corp?
The 52-week low of QuidelOrtho Corp is 9.92.
What is the market capitalization of QuidelOrtho Corp?
The market capitalization of QuidelOrtho Corp is 1.14B.
Is QuidelOrtho Corp (QDEL) currently rated as Buy, Hold, or Sell?
According to analysts, QuidelOrtho Corp (QDEL) has an overall rating of signal_hold, with a price target of 26.00.
What is the Earnings Per Share (EPS TTM) of QuidelOrtho Corp (QDEL)?
The Earnings Per Share (EPS TTM) of QuidelOrtho Corp (QDEL) is -16.69.